Course Summary
Contact Hour(s):
2 Contact Hours, including 2 Pharmacology Hours
Author:
Heather Rhodes, APRN-BC
This peer-reviewed course is applicable for the following professions:
Advanced Practice Registered Nurse (APRN), Certified Nurse Practitioner, Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Nursing Student, Registered Nurse (RN), Registered Nurse Practitioner
Accreditations:
The American Nurses Credentialing Center (ANCC)
State Approvals:
Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353
Course Description:
This course discusses what pharmacogenomic testing is and how it can benefit patients. Genes, pathways, and drug-drug interactions are also outlined.
Outcomes:
≥ 92% of participants will understand pharmacogenomic testing indications, the benefits of testing, how to perform the test, read the results, and be able to recommend treatment options.
Objectives:
After completing this continuing education course, the participant will be able to:
- Describe what pharmacogenomic testing is and how it helps patients.
- Describe who regulates pharmacogenomic testing.
- Determine patients who are appropriate for pharmacogenomic testing.
- Explain the difference between pharmacodynamic and pharmacokinetic genes.
- Compare cytochrome P450 (CYP) enzymatic pathways.
- Recall the most common mechanism leading to drug-drug interactions.
Disclosures:
CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.